Table VI.

First Series of Assessments: Variation in Impactor-Measured MMAD from Cumulative APSD Data for DPI Inhaler “A”

Impactor	Sample duration (s)	MMAD (μm)
NGI	1	5.3
	2	4.1
	4	4.1
	8	4.0
	16	4.2
	Referencea	4.1
ACI	1	3.5
	2	3.6
	4	3.6
	8	3.7
	16	3.6
	Referencea	3.6

^aSeven actuations from inhaler in accordance with standardized procedure in effect at GSK plc